August 2007 | Main | December 2007
Are there vaccines?
Many thanks to everyone who attended the film tonight.
Someone asked if the vaccine has become a reality.
From the CDC site, it mentions that the vaccine is not commercially available in the US.
More articles have been posted below. Use the comments feature to share info that you have found on the topic.
Thanks!
Posted by Donna Braquet at 08:16 PM | Comments (1)
Info about Plague
Posted by Donna Braquet at 07:59 PM
New combination vaccine effective against plague
New combination vaccine effective against plague
Disease/Infection News
Published: Wednesday, 18-May-2005
Plague, a bacterium that ravaged Europe in the Middle Ages and is today one of the most feared potential agents of bio-terrorism, may have met its match, according to Wake Forest University School of Medicine scientists.
Steven B. Mizel, Ph.D., principal investigator, told the American Gastroenterological Association meeting in Chicago that when mice immunized with a new combination vaccine were challenged with a lethal dose of Yersinia pestis, the bacterium that causes plague, "the immune mice survived but the control mice succumbed in three days."
Mizel and his graduate student, Anna Honko, found that injecting a protein taken from plague bacteria into a mouse - one method of vaccination - produces little if any response in the mouse immune system. But if a protein termed flagellin is added to the vaccine, antibody levels against the plague bacteria are 500,000 times higher.
Read More>>
http://www.news-medical.net/?id=10193
Posted by Donna Braquet at 07:55 PM
Scientists edge closer to a vaccine for plague
By Eric NagourneyPublished: WEDNESDAY, JANUARY 18, 2006
Researchers say they have taken a step toward developing a reliable vaccine against the plague.
The disease takes two forms: bubonic, which is spread by flea bites, and the more serious pneumonic, which is spread in the air. Government officials are concerned that it could also be used as a weapon.
Read more>>
http://www.iht.com/articles/2006/01/18/healthscience/snvital.php
Posted by Donna Braquet at 07:52 PM
New case of bubonic plague in N.M.
SANTA FE (AP) - New Mexico has another case of bubonic plague, the fifth this year. The state Department of Health has confirmed the case in a 58-year-old woman who lives in the mountains east of Albuquerque in Bernalillo County.
Read the full article>>
http://kob.com/article/stories/S210003.shtml?cat=516
Posted by Donna Braquet at 07:47 PM
Deadly Toxins Involved in Mishaps
Reports reveal dozens of accidents involving deadliest toxins at U.S. labs
By LARRY MARGASAK
The Associated Press
WASHINGTON | American laboratories handling the world's deadliest germs and toxins have experienced more than 100 accidents and missing shipments since 2003 -- including five in Kansas City.
Read the full article>>
http://www.kansascity.com/105/story/300842.html
Posted by Donna Braquet at 07:44 PM
Plague Vaccine Agreement Signed
A joint, multi-nation project arrangement between the U.S. Department of Defense (DoD), the Department of National Defence of Canada, and the Secretary of State for Defense of the United Kingdom of Great Britain and Northern Ireland was announced today for the cooperative development of a vaccine to protect against plague. Under this agreement, the three nations will work together to develop and produce a plague vaccine that will ultimately be licensed for human use.
The defense establishments of the United States and the U.K. have each maintained active plague vaccine research and development efforts since the 1990s. Relevant plague vaccine development information has been shared among the U.S., U.K., and Canada under provisions of a memorandum of understanding between the three nations since 2000.
The U.K. plague vaccine candidate is a purified subunit vaccine containing the F1 and V antigens purified separately from recombinant Escherichia coli and then mixed together, while the DoD vaccine candidate contains the F1 and V antigens linked together as a fusion protein. The F1V fusion protein candidate was pioneered by the U.S. Army Medical Research Institute of Infectious Diseases, of the U.S. Army Medical Research and Materiel Command. The DoD program is now managed by the Joint Vaccine Acquisition Program in the office of the Joint Program Executive Office for Chemical and Biological Defense.
Testing of the U.K. plague vaccine candidate in the United States under the joint project arrangement is expected to begin in late 2005 with a phase one clinical trial to be performed in accordance with regulations administered by the Food and Drug Administration (FDA). The DoD plague vaccine candidate began phase one clinical trials, at the University of Kentucky, in the first quarter of 2005. This joint effort will continue until late 2005, at which time the DoD will evaluate both vaccine candidates and select one for continued advanced development.
http://www.defenselink.mil/releases/release.aspx?releaseid=8397
Posted by Donna Braquet at 07:42 PM